Gyeonggi-do, South Korea

Tae Geon Oh

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Catholic University of Korea. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tae Geon Oh - Innovator in Radiotherapy Technology

Introduction

Tae Geon Oh is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of radiotherapy through his innovative designs and patents. His work focuses on improving the accuracy and effectiveness of cancer treatment.

Latest Patents

Tae Geon Oh holds a patent for a "Lung Phantom Unit for Radiotherapy." This invention allows for the arrangement of a phantom driving cylinder and a driving device that can move a lung mimic and a tumor mimic within a lung simulation block. The lung phantom unit is versatile and can be utilized for MRI-based and CT image-based radiotherapy. By implementing lung and tumor motions through air injection, it enables precise measurement of motion and volume changes in the lung, accommodating various patient breathing patterns. He has 1 patent to his name.

Career Highlights

Tae Geon Oh is affiliated with The Catholic University of Korea, where he continues to advance research in medical technology. His work is instrumental in enhancing the quality of care for patients undergoing radiotherapy.

Collaborations

He collaborates with talented colleagues, including Yun Ji Seol and Jin Ho Hwang, who contribute to his research and development efforts.

Conclusion

Tae Geon Oh's innovative contributions to radiotherapy technology demonstrate his commitment to improving patient outcomes. His work exemplifies the importance of advancements in medical technology for effective cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…